Objective: To compare severe pregnancy complications in ART singleton pregnancies treated with anticoagulation due to thrombophilia to low-risk, spontaneously conceived untreated pregnancies. Design: Retrospective case control.Setting: New York Presbyterian-Brooklyn Methodist Hospital, Brooklyn New York.Patients: 615 ART pregnancies compared with 391 low-risk, untreated pregnancies matched for age and time of delivery.Interventions: ART pregnancies were treated with LMWH and low dose aspirin daily and managed by MFM specialist during the entire pregnancy. Main Outcome Measures:Compared for intrauterine growth restriction (IUGR), preterm premature rupture of membranes (pPROM), thrombocytopenia, prematurity, preeclampsia, abruption, and fetal death. Results:The incidence of IUGR was significantly lower in the ART group (5.05% vs. 9.21%, p<0.01). Preeclampsia was significantly reduced in the ART group in comparison to the control, 1.14 % vs. 6.39 %, p<0.0001. PPROM was significantly reduced in the ART group in comparison to the control, 1.46 % vs. 7.67 %, p< 0.0001. Prematurity was reduced in the ART group, 3.43% vs. 9.72%, p<0.0001. Thrombocytopenia incidence was similar, 2.28 % vs. 2.05 %, p > 0.8. Abruption was similar in the two groups, ART 1.3 % vs. 1.02 %, p >0.68. There were more fetal deaths in the control group but due to the small numbers in both groups, statistical comparison was not possible. Conclusion:Use of antithrombotics in ART conceived singleton gestations complicated by thrombophilia under MFM specialty care resulted in significantly decreased prevalence of most major obstetrical complications when compared to low-risk unselected untreated pregnancies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.